Evidence map›Paper›PMID 39545730›Full record

ReviewClinical microbiology reviews2024

Animal models for exploring Chagas disease pathogenesis and supporting drug discovery.

Archie A Khan, Martin C Taylor, Amanda Fortes Francisco, Shiromani Jayawardhana, Richard L Atherton, Francisco Olmo, Michael D Lewis, John M Kelly

Abstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Fighting Strategies Against Chagas' Disease: A Review.Pathogens (Basel, Switzerland) · 2025
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Archie A Khan *Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Martin C Taylor *Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Amanda Fortes FranciscoDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Shiromani JayawardhanaDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Richard L AthertonDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Francisco OlmoDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Michael D LewisDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
John M KellyDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0003-4305-5258

Funding

Drugs for Neglected Diseases initiative (DNDi)UKRI | Medical Research Council (MRC) MR/R021430/1UKRI | Medical Research Council (MRC) MR/T015969/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chagas DiseaseDisease Models, AnimalDrug DiscoveryTrypanosoma cruziAnimalsanimal modelsChagas diseasedrug developmentpathogenesisTrypanosoma cruzi

Identifiers

PMID39545730
PMCPMC11629624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.